3Laumbacher B, Gu S, Wank R. Activated monocytes prime naive T cells against autologous cancer: vigorous cancer destruction in vitro and in vivo [J]. Scand J Im- munol, 2012,75 (3) : 314-328.
3LEGHA S S. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy [J ]. Semin Oncol , 1997, (Supp124) : S39 - 43.
4PARKIN D M,BRAY F,FERAY J,et al. Global cancer statistics [J]. 2002.CA Cancer J Clin,2005,55:74 - 108.
5SWENSON K K, HENLY S J, SHAPIRO A C,et al. Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer[ J ]. Clin J Oncol Nurs, 2005,9(2) : 177 - 184.
6WANK, RUDOLF. Use of stimulated peripheral blood mononuclear ceils for treating cancerous diseases :Germany, WO 02/087612 A2[ P ].2002 - 07 - 11.
7KHAYAT D, BERNARD MARTY C, MERIC J B,et al. Biochemotherapy for advanced melanoma:maybe it is real [J]. J Clin Oncol,2002,20(10) :2411 - 2414.
8VOGEL C L,COBLEIGH M A,TRIPATHY D,et al. First-line herceptin monotherapy in metastatic breast cancer [ J ]. Oncology, 2001,10(61 Suppl S2) : 37 - 42.
9KOWOLIK C M,TOPP M S,GONZALEZ S,et al. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T ceils [J]. Cancer Res, 2006,66 (22) : 10995 - 11004.
10JARVINEN T A, LIU E T. Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes-molecular basis for combination chemotherapy in cancer [J]. Curr Cancer Drug Targets,2006,6 (7): 579 - 602.
